158 related articles for article (PubMed ID: 32838584)
1. Antiviral therapy for the sexually transmitted viruses: recent updates on vaccine development.
Kardani K; Basimi P; Fekri M; Bolhassani A
Expert Rev Clin Pharmacol; 2020 Sep; 13(9):1001-1046. PubMed ID: 32838584
[TBL] [Abstract][Full Text] [Related]
2. Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases.
Dorosti H; Eskandari S; Zarei M; Nezafat N; Ghasemi Y
Infect Genet Evol; 2021 Dec; 96():105136. PubMed ID: 34775078
[TBL] [Abstract][Full Text] [Related]
3. [Experimental vaccines for sexually transmitted infections].
Jovanović M; Karadaglić D; Golusin Z; Brkić S; Poljacki M
Med Pregl; 2009; 62(1-2):42-8. PubMed ID: 19514600
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
J Virol; 2017 May; 91(9):. PubMed ID: 28228587
[TBL] [Abstract][Full Text] [Related]
5. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
Chmielewska AM; Naddeo M; Capone S; Ammendola V; Hu K; Meredith L; Verhoye L; Rychlowska M; Rappuoli R; Ulmer JB; Colloca S; Nicosia A; Cortese R; Leroux-Roels G; Balfe P; Bienkowska-Szewczyk K; Meuleman P; McKeating JA; Folgori A
J Virol; 2014 May; 88(10):5502-10. PubMed ID: 24599994
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of viral sexually transmitted infections and HPV high-risk genotypes in women in rural communities in the Department of La Paz, Bolivia.
Patzi-Churqui M; Terrazas-Aranda K; Liljeqvist JÅ; Lindh M; Eriksson K
BMC Infect Dis; 2020 Mar; 20(1):204. PubMed ID: 32143643
[TBL] [Abstract][Full Text] [Related]
7. Sexually transmitted viruses.
Rapp F
Yale J Biol Med; 1989; 62(2):173-85. PubMed ID: 2549736
[TBL] [Abstract][Full Text] [Related]
8. [Viral sexually transmitted diseases and their treatments].
Parent D; Binet H
Rev Med Brux; 1998 Sep; 19(4):A185-90. PubMed ID: 9805942
[TBL] [Abstract][Full Text] [Related]
9. Papillomavirus-like particle vaccines.
Schiller JT; Lowy DR
J Natl Cancer Inst Monogr; 2001; (28):50-4. PubMed ID: 11158207
[TBL] [Abstract][Full Text] [Related]
10. Vaccination against sexually transmitted infections.
Fairley CK; Read TR
Curr Opin Infect Dis; 2012 Feb; 25(1):66-72. PubMed ID: 22143117
[TBL] [Abstract][Full Text] [Related]
11. Sexually transmitted infections among prostitutes in Bratislava, Slovakia.
Bystrická M; Kriková Z; Kŕcová M; Koncová K; Kovácová E; Vaculíková A; Staneková D; Russ G
Acta Virol; 2003; 47(3):167-72. PubMed ID: 14658845
[TBL] [Abstract][Full Text] [Related]
12. Natural polyphenols: potential in the prevention of sexually transmitted viral infections.
Date AA; Destache CJ
Drug Discov Today; 2016 Feb; 21(2):333-41. PubMed ID: 26546859
[TBL] [Abstract][Full Text] [Related]
13. Multivalent DNA vaccine protects against genital herpes by T-cell immune induction in vaginal mucosa.
Kim HC; Oh DS; Park JH; Kim HJ; Seo YB; Yoo HJ; Jang HS; Shin J; Kim CW; Kwon MS; Jin HT; Lee SK; Oh JE; Lee HK
Antiviral Res; 2020 May; 177():104755. PubMed ID: 32112797
[TBL] [Abstract][Full Text] [Related]
14. The traditional use of Vachellia nilotica for sexually transmitted diseases is substantiated by the antiviral activity of its bark extract against sexually transmitted viruses.
Donalisio M; Cagno V; Civra A; Gibellini D; Musumeci G; Rittà M; Ghosh M; Lembo D
J Ethnopharmacol; 2018 Mar; 213():403-408. PubMed ID: 29203273
[TBL] [Abstract][Full Text] [Related]
15. First report on sexually transmitted infections among trans (male to female transvestites, transsexuals, or transgender) and male sex workers in Argentina: high HIV, HPV, HBV, and syphilis prevalence.
Dos Ramos Farías MS; Garcia MN; Reynaga E; Romero M; Vaulet ML; Fermepín MR; Toscano MF; Rey J; Marone R; Squiquera L; González JV; Basiletti J; Picconi MA; Pando MA; Avila MM
Int J Infect Dis; 2011 Sep; 15(9):e635-40. PubMed ID: 21742530
[TBL] [Abstract][Full Text] [Related]
16. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
[TBL] [Abstract][Full Text] [Related]
17. Bicistronic DNA vaccines simultaneously encoding HIV, HSV and HPV antigens promote CD8⁺ T cell responses and protective immunity.
Santana VC; Diniz MO; Cariri FA; Ventura AM; Cunha-Neto E; Almeida RR; Campos MA; Lima GK; Ferreira LC
PLoS One; 2013; 8(8):e71322. PubMed ID: 23951135
[TBL] [Abstract][Full Text] [Related]
18. The next generation of HCV vaccines: a focus on novel adjuvant development.
Kardani K; Sadat SM; Kardani M; Bolhassani A
Expert Rev Vaccines; 2021 Jul; 20(7):839-855. PubMed ID: 34114513
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of sexually transmitted viruses in the tribal population of Central India.
Anvikar AR; Rao VG; Savargaonkar DD; Rajiv Y; Bhondeley MK; Tiwari B; Karkare A; Luke C; Gadge V; Ukey M; Patel P
Int J Infect Dis; 2009 Jan; 13(1):37-9. PubMed ID: 18573674
[TBL] [Abstract][Full Text] [Related]
20. Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes.
Bernstein DI; Cardin RD; Bravo FJ; Hamouda T; Pullum DA; Cohen G; Bitko V; Fattom A
Vaccine; 2019 Oct; 37(43):6470-6477. PubMed ID: 31515143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
